Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation
1 other identifier
interventional
400
2 countries
2
Brief Summary
Despite Transcatheter aortic valve implantation (TAVI) evolution regarding techniques, equipment and experience, the need for permanent pacemaker implantation (PPI) post-TAVI remains an important drawback. The electrophysiology testing to stratify the risk or necessity of PPI post-TAVI is endorsed by the up-to-date guidelines and consensus documents and it is a valuable cut-off based method. Part of the answer is maybe hidden in the easy and applicable testing of the atrioventricular conduction system through rapid atrial pacing (RAP) with a common temporary pacemaker lead. This trial is designed to investigate the role and value of RAP after TAVI as a predictor of the necessity of new PPI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2023
CompletedFirst Posted
Study publicly available on registry
January 5, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 12, 2024
December 1, 2024
1.2 years
December 17, 2023
December 9, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Permanent pacemaker implantation rates
Rates of permanent pacemaker implantation after TAVI
30 days
Secondary Outcomes (5)
Mortality rates
30 days
Mortality rates
6 months
Permanent pacemaker implantation rates
6 months
Mortality rates
12 months
Permanent pacemaker implantation rates
12 months
Study Arms (1)
Rapid atrial pacing
OTHERDiagnostic test group (single group)
Interventions
Eligibility Criteria
You may qualify if:
- Adults ≥18 years old.
- Patient understands the purpose, the potential risks as well as benefits of the trial and is willing to participate in all parts of the follow-up.
- Patient has given written consent to participate in the trial.
- Patients undergoing TAVI as a treatment of severe aortic stenosis (AS).
- Patient in sinus rhythm.
- Patients planned for TAVI with utilization of temporary pacemaker electrode placement.
You may not qualify if:
- Ongoing infection, including active endocarditis.
- Implanted permanent pacemaker and/or implantable cardioverter/defibrillator.
- Patients developing persistent second or third degree atrioventricular block (AV) after TAVI.
- Underlying rhythm other than sinus based on the surface ECG leads monitoring after TAVI.
- Patients with second or third degree AV block identifyied on the screening pre-TAVI ECG.
- Enrolment in another study that competes or interferes with this study.
- Subject will not be able to comply with the follow-up requirements according to investigators' opinion.
- Pregnant or breast-feeding females or females who intend to become pregnant during the time of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Saint-Pierre
Brussels, 1000, Belgium
Hippocration Hospital
Athens, Attica, 11527, Greece
Related Publications (4)
Knecht S, Schaer B, Reichlin T, Spies F, Madaffari A, Vischer A, Fahrni G, Jeger R, Kaiser C, Osswald S, Sticherling C, Kuhne M. Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. J Am Heart Assoc. 2020 Mar 3;9(5):e014446. doi: 10.1161/JAHA.119.014446. Epub 2020 Feb 22.
PMID: 32089049RESULTKrishnaswamy A, Sammour Y, Mangieri A, Kadri A, Karrthik A, Banerjee K, Kaur M, Giannini F, Pagliaro B, Ancona M, Pagnesi M, Laricchia A, Weisz G, Lyden M, Bazarbashi N, Gad M, Ahuja K, Mick S, Svensson L, Puri R, Reed G, Rickard J, Colombo A, Kapadia S, Latib A. The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation. JACC Cardiovasc Interv. 2020 May 11;13(9):1046-1054. doi: 10.1016/j.jcin.2020.01.215. Epub 2020 Apr 15.
PMID: 32305392RESULTTan BE, Hashem A, Boppana LKT, Mohamed MS, Abbas SF, Faisaluddin M, Thakkar S, Ahmed AK, Hall C, Abtahian F, Rao M, Bhatt DL, Depta JP. Utility of rapid atrial pacing before and after TAVR with balloon-expandable valve in predicting permanent pacemaker implantation. Catheter Cardiovasc Interv. 2023 Nov;102(5):919-928. doi: 10.1002/ccd.30817. Epub 2023 Sep 12.
PMID: 37698294RESULTKoliastasis L, Doundoulakis I, Tsiachris D, Pannone L, Skalidis I, de Hemptinne Q, Xaplanteris P, Toutouzas K, de Asmundis C. Rapid Atrial Pacing After TAVI for Pacemaker Prediction. Rev Cardiovasc Med. 2025 Aug 15;26(8):39074. doi: 10.31083/RCM39074. eCollection 2025 Aug.
PMID: 40927105DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leonidas Koliastasis
National and Kapodistrian University of Athens
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Interventional Cardiology Fellow
Study Record Dates
First Submitted
December 17, 2023
First Posted
January 5, 2024
Study Start
March 1, 2024
Primary Completion
April 30, 2025
Study Completion
December 31, 2025
Last Updated
December 12, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share